scholarly journals Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy

2016 ◽  
Vol 170 (3) ◽  
pp. 187-193 ◽  
Author(s):  
Sjors A. Koppes ◽  
Richard Brans ◽  
Suzana Ljubojevic Hadzavdic ◽  
Monique H.W. Frings-Dresen ◽  
Thomas Rustemeyer ◽  
...  
2019 ◽  
Vol 139 (11) ◽  
pp. 2387-2389.e1 ◽  
Author(s):  
Byung Eui Kim ◽  
Elena Goleva ◽  
Peter S. Kim ◽  
Kathryn Norquest ◽  
Caroline Bronchick ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Maja-Lisa Clausen ◽  
H.-C. Slotved ◽  
Karen A. Krogfelt ◽  
Tove Agner

Dermatology ◽  
2021 ◽  
pp. 1-6
Author(s):  
Stine Simonsen ◽  
Peter Brøgger ◽  
Sanja Kezic ◽  
Jacob P. Thyssen ◽  
Lone Skov

Skin biomarkers for disease severity and treatment response in atopic dermatitis (AD) are needed. Biopsies cause scarring and tape stripping represents an alternative minimally invasive method for stratum corneum sampling. In this study, we examined the gene expression of cytokines in skin biopsies and cytokines in stratum corneum tape strips collected from adults with AD. We collected punch biopsies and tape strips from healthy controls (<i>n</i> = 6) and subjects with AD (<i>n</i> = 12) at baseline and after 2 weeks of topical treatment with mometasone furoate 0.1% cream. We found that IFN-γ, IL-13, and IL-10 mRNA (biopsies) and IL-1β protein expression levels (tape strips) were significantly increased in lesional AD skin compared to healthy control skin. Treatment with topical corticosteroid led to a significant decrease in mRNA levels for IL-13 and IL-4R but no significant differences in cytokine protein levels measured in tape strips. Finally, we found no significant correlations between cytokine levels in tape strips and mRNA levels in skin biopsies.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Maja-Lisa Clausen ◽  
S. Kezic ◽  
C. M. Olesen ◽  
T. Agner

AbstractTape stripping is a promising technique for assessment of epidermal biomarkers in inflammatory skin diseases. However, to facilitate its implementation in the clinical practice, a thorough validation regarding sampling strategy is needed. Knowledge of biomarkers variation in concentration across stratum corneum is scarce. Therefore, this study aimed to assess the variability of cytokines across stratum corneum using tape stripping technique by consecutive application of 21 adhesive tapes (D-squame) to lesional and non-lesional skin from 15 patients with atopic dermatitis (AD) and 16 healthy controls. Concentration of cytokines (IL-1α, IL-1b, IL-5, IL-18, IFN-γ, CCL17, CCL22, CCL27, CXCL8, CXCL10, TNF-α, TSLP, VEGFA) was determined in five different depths, using multiplex immunoassay. Comparing tape 4 with tape 21, no cytokine changed significantly in concentration in AD lesional skin. In AD non-lesional skin a small decrease was found for CCL17, CXCL8 and CXCL10. For healthy controls, a decrease was found for IL-1a, IL-1b, VEGFA and an increase for IL-18. Differences were found between AD skin and healthy control skin. Concentration of cytokines was stable across stratum corneum, indicating that sampling of only one tape from the stratum corneum is reliable in reflecting the overall cytokine milieu. Differences between AD and healthy skin confirm robustness of tape stripping for measuring cytokine levels.


PLoS ONE ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. e0210013 ◽  
Author(s):  
Takahito Chiba ◽  
Takeshi Nakahara ◽  
Futoshi Kohda ◽  
Toshio Ichiki ◽  
Motomu Manabe ◽  
...  

Author(s):  
Susumu Murata ◽  
Sakae Kaneko ◽  
Eishin Morita

<b><i>Introduction:</i></b> The stratum corneum contains several growth factors and cytokines that are synthesized in keratinocytes. We previously reported that the amount of interleukin-8 in the stratum corneum (scIL-8) is related to the severity of local skin inflammation in atopic dermatitis (AD). However, it is unknown whether scIL-8 levels reflect pharmacologic responses to a therapeutic intervention in AD patients. Therefore, in this study, we aimed to investigate whether the improvement of dermatitis in AD is correlated with scIL-8 levels before and after topical corticosteroid treatment. <b><i>Methods:</i></b> Stratum corneum samples were collected from 22 AD patients using the noninvasive tape-stripping method before treatment, 2 weeks after topical treatment, and 4–6 weeks after treatment. <b><i>Results:</i></b> scIL-8 levels on the forearm reduced significantly from 790 ± 348 pg/mg before treatment to 163 ± 68 pg/mg 2 weeks after treatment and 100 ± 37 pg/mg 4–6 weeks after corticosteroid treatment. scIL-8 levels on the abdomen also reduced significantly from 902 ± 391 to 142 ± 38 pg/mg at the end of study. The reduction in scIL-8 levels was associated with the improvement in local skin severity in AD. We also found that scIL-8 levels, along with blood biomarker levels (serum thymus and activation-regulated chemokine, lactate dehydrogenase, and %eosinophil), decreased significantly after the treatment. <b><i>Conclusion:</i></b> The scIL-8 concentration decreases with improvements in skin symptoms in AD patients after topical corticosteroid treatment; thus, it may be a suitable biomarker for monitoring therapeutic effects in AD patients.


Author(s):  
Julie Sølberg ◽  
Stine B. Jacobsen ◽  
Jeppe D. Andersen ◽  
Thomas Litman ◽  
Nina H. Ulrich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document